Sp628

WHAT IS THE SCIENCE TO ELIMINATION DIETS IN IBS

Date
May 19, 2024
Explore related products in the following collection:

Presenter

Speaker Image for Prashant Singh
University of Michigan

Tracks

Related Products

Thumbnail for A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Thumbnail for EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
EFFICACY OF A NOVEL, DISCRIMATORY P-VALUE BASED, IGG ASSAY-GUIDED ELIMINATION DIET BY IBS SUBTYPE: RESULTS FROM A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED STUDY
INTRODUCTION: There is a lack of data on the efficacy of dietary therapies by IBS subtype (IBS-D, IBS-C, and IBS-M)…
Thumbnail for Irritable Bowel Syndrome Clinical
Irritable Bowel Syndrome Clinical
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Thumbnail for SYMPTOMS DO NOT PREDICT SUCROSE MALABSORPTION ON BREATH TESTING
SYMPTOMS DO NOT PREDICT SUCROSE MALABSORPTION ON BREATH TESTING
Sucrose malabsorption and small intestinal bacterial overgrowth (SIBO) both have symptoms that overlap with common functional gastrointestinal disorders (FGID). These common symptoms include abdominal pain/cramping, bloating, and diarrhea…